Cel Sci Corporation (CVM)

[RobotDroid]

Yep, LEAPS is also VERY important. Valution is tough as realistically, you could make a case (if we stay at about 33 million in the float) for $25 pre trial data, and anywhere from 4 billion ($121 a share) to 8 billion ($242 a share) or even more. Imagine if it can show improvement on breast cancer, that is priceless. Then in combo with other drugs, or if more injections beyond 3 improves tumor shrinkage, etc. The sky is the limit if MK works like P2, and my bet is it does.